Abnormal glucose metabolism in people admitted to hospital experiencing an acute coronary syndrome (ACS) strongly predicts development of type 2 diabetes and future cardiovascular events. This paper describes a prospective nine-month parallel design randomised intervention trial involving people admitted to the Wellington Regional Heart and Lung Unit with ACS and hyperglycaemia.
Approximately 110,000 patients are admitted to hospital each year in the UK with acute coronary syndromes. What is the pathophysiology and how should these patients be managed in primary care?
Troponins are now measured routinely in patients with acute chest pain in most hospitals in the UK. Studies have confirmed that they represent a marker of risk for subsequent cardiac events in most patients. In this article we explore what troponins are, why they may increase in acute coronary syndromes, how they are measured and how likely they are to be used in the future.
Acute coronary syndromes (ACS) include common and high-risk conditions such as unstable angina, which can be difficult to diagnose, particularly in women, the elderly and diabetics. Early identification and appropriate management can significantly reduce the risk of death, morbidity and subsequent hospital admissions. This article aims to clarify what happens in ACS, how they present and how they should be managed.